Clinical trials in Katowice – page 38

736 clinical trials in Katowice, Poland across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Katowice at a glance

736

clinical trials

Research sites18

Quick filters

736 trials in Katowice

Open in trial search

Familial hypertriglyceridaemia+1

Not recruiting

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational

Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Isis 678354 Sodium Salt
Sponsor:Ionis Pharmaceuticals Inc.

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Beclometasone Dipropionate Anhydrous
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Prophylaxis+1

Not recruiting

Study on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma

Registered drugNo placebo

Study on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Salbutamol Sulfate
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Parkinson's disease

Not recruiting

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Tavapadon
Sponsor:Cerevel Therapeutics LLC

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on Masupirdine for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Study on Masupirdine for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Masupirdine
Sponsor:Suven Life Sciences Limited

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Dermatitis atopic

Not recruiting

Study on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis

Investigational

Study on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Humanised Igg1 Kappa Monoclonal Antibody Against Interleukin 18
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Atuliflapon
Sponsor:AstraZeneca AB

Contact Research Centre

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Asundexian
Sponsor:Bayer AG

Contact Research Centre

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Obicetrapib
Sponsor:NewAmsterdam Pharma B.V.

Contact Research Centre

Multiple sclerosis

Not recruiting

Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo

Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Methylprednisolone
Sponsor:Celltrion Inc.

Contact Research Centre

Androgenetic alopecia

Not recruiting

Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

Investigational

Study on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Clascoterone
Sponsor:Cassiopea S.p.A.

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Katowice

What the registry says about research in the country

01 Respiratory Conditions

Research focusing on respiratory health conditions, including studies on RSV infections in older adults and treatments for chronic obstructive pulmonary disease. Current trials are evaluating new vaccines and investigating innovative therapies for chronic rhinosinusitis.

RSV Vaccine Studies
COPD Treatment Evaluation
Chronic Rhinosinusitis Management

02 Neurological Disorders

Innovative research into neurodegenerative conditions, with a particular focus on Parkinson's disease treatments. Studies are examining new therapeutic approaches and investigating targeted treatments for early-stage Parkinson's.

Early Parkinson's Disease Interventions
LRRK2-Driven Parkinson's Research
Generalized Myasthenia Gravis Treatment

03 Dermatological Conditions

Comprehensive studies on inflammatory skin conditions, including trials for moderate to severe plaque psoriasis, genital psoriasis, and atopic dermatitis. Research focuses on evaluating new biological treatments and innovative therapies.

Plaque Psoriasis Treatments
Atopic Dermatitis Management
Novel Therapeutic Approaches

04 Oncology and Hematology

Advanced research in cancer treatment, particularly focusing on blood cancers and prostate cancer. Studies include innovative approaches for treating diffuse large B-cell lymphoma and acute myeloid leukemia.

Lymphoma Therapies
Leukemia Treatments
Prostate Cancer Management

05 Autoimmune Conditions

Research investigating treatments for various autoimmune disorders, including Sjögren's Syndrome and chronic inflammatory demyelinating polyneuropathy. Studies focus on evaluating new therapeutic agents and their long-term effectiveness.

Sjögren's Disease Therapies
CIDP Treatment Approaches
Inflammatory Disease Management

Back to Poland All countries